drug safety
Trump’s FDA: Is the US regulator being steered by the President?
September 9, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, Trump, US, drug safety, pharma
FDA activity has fallen under Donald Trump, with the number of warning letters issued by the regulator dropping by a …
PV futures: Pharmacovigilance as a solution to the challenges of tomorrow
March 11, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing drug safety, feature, pharma, pharmacovigilance
Louis Goss asks what the future might hold for the safety of pharmaceuticals and looks into why crucial pharmacovigilance practices …
Drug safety: UK and EU post-Brexit
September 10, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, EU, Europe, MHRA, UK, brexit, drug safety, pharmacovigilance
What does Brexit mean for drug safety in Europe and the United Kingdom? Louis Goss looks into Britain’s exit from …
The September 2018 issue of Pharmafocus is available to read online now!
September 3, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alzheimer's, AstraZeneca, Cancer, Iraw, J&J, JJ, Pfizer, Roche, UK, brexit, drug safety, pharma, pharmacovigilance
The new September edition of Pharmafocus is now live and available to read online. We’re entering the final stretch as …
CCP fire provincial official and investigate drug regulator in response to Changsheng vaccine scandal
August 17, 2018Medical Communications China, Vaccine, changsheng, drug safety, regulation
The Chinese government has fired a senior provincial official and is probing a former senior drug regulator in response to …
Drug safety: EudraVigilance and an evolving system
March 12, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing drug safety, pharma, pharmacovigilance
The importance of drug safety is back in the news due to sodium valproate and Ben Hargreaves examines how the …
Pharmafocus March 2018 is available to read online now!
February 28, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmafocus, brexit, drug safety, pharma, real world data
Though never truly out of vogue, the drug pricing debate has flared up again with the White House’s release of …
Asking the right questions: Measuring the impact of pharmacovigilance
October 16, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing drug safety, pharma, pharmacovigilance
Are our pharmacovigilance measures as effective as we think? And why is it important to answer that question, especially now? …
EMA concludes HPV vaccines do not cause CRPS or POTS
November 9, 2015Sales and Marketing EMA, HPV, HPV vaccine, PRAC, complex regional pain syndrome, drug safety, postural orthostatic tachycardia syndrome
The European Medicines Agency says there is no evidence from a detailed scientific review of reports linking complex regional pain …
AstraZeneca halts lung cancer trials amidst safety concerns
October 13, 2015Manufacturing and Production AZD9291, AstraZeneca, MEDI4736, NSCLC, drug safety, durvalumab, interstitial lung disease, lung cancer, non-small cell lung cancer
AstraZeneca is stopping two trials of a combination of two of its pipeline cancer treatments, after reports that the pairing …
Pfizer and GSK in antidepressant safety probes
September 22, 2015Manufacturing and Production GSK, Paxil, Pfizer, Zoloft, antidepressants, drug safety, paroxetine, sertraline
Two top-selling antidepressants have had their safety records challenges, after the FDA asked Pfizer to change the labelling of its …
FDA issues gliptin joint pain warning
September 1, 2015Manufacturing and Production DPP-4 inhibitors, ESC, FDA, TECOS, adverse effects, drug safety, gliptins, safety alert, safety warning
The FDA has issued a safety alert, warning of joint pain caused by the gliptins, a common class of drugs …
Spiriva mist inhaler safety concerns raised
June 16, 2011Sales and Marketing Boehringer Ingelheim, Spiriva, drug safety
A mist inhaler used to deliver Spiriva to patients with chronic obstructive pulmonary disease (COPD) may be linked to an …
French pharma firm denies drug risk cover up
May 10, 2011Sales and Marketing Mediator, Servier, drug safety
France’s second biggest pharma firm Servier has denied allegations it concealed risks associated with its diabetes drug Mediator (benfluorex). Research …
Servier’s Mediator provokes French drug safety controversy
January 12, 2011Sales and Marketing AFSSAPS, France, Mediator, Servier, benfluorex, drug safety
Serious questions are being asked about drug safety monitoring in France in connection with Servier’s Mediator (benfluorex) which was withdrawn …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
